Transient hemolytic anemia after kidney transplantation and thrombotic thrombocytopenic purpura refractory to plasma exchange and rituximab.
Herwig
H
Pieringer
Bernhard
B
Schmekal
Franz
F
Gruber
Milan R
MR
Vosko
Georg
G
Biesenbach
D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000175:diagnosis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000379:methods; D010951:Plasma Exchange / Q000379:methods*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D018570:Risk Assessment; D000069283:Rituximab; D012720:Severity of Illness Index; D012771:Shock, Hemorrhagic / Q000175:diagnosis / Q000628:therapy; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab